On November 6 and 7, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 7th NIKKEI FT Communicable Diseases Conference, which was entitled “Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation.” The event was co-hosted by the NIKKEI and the Financial Times.

For details, please visit the event website, which can be found here.

Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.

Friday, November 6, 2020
Lunch Session- BD Japan: The role of testing in communicable diseases～Learning from COVID-19
Moderator: Ryoji Noritake (HGPI Board Member and CEO)

Breakout Session A-1: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)

Breakout Session A-2: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)

Saturday, November 7, 2020
Keynote Session- Dr. Yasuhiro Suzuki, Former Vice-Minister for Health／Chief Medical & Global Health Officer, MHLW, Japan
Discusser: Kiyoshi Kurokawa (HGPI Chairman)

Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)

Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)

Agenda6- Coexisting with COVID-19 ～The Role of Japanese Initiatives
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Discusser: Kiyoshi Kurokawa (HGPI Chairman)

Summary Session
Discusser: Ryoji Noritake (HGPI Board Member and CEO)

Conclusion/Statement
Discusser: Ryoji Noritake (HGPI Board Member and CEO)